ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jegaden, O.
Right arrow Articles by Mikaeloff, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jegaden, O.
Right arrow Articles by Mikaeloff, P. H.

The Annals of Thoracic Surgery, Vol 58, 1721-1728, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve

O Jegaden, A Eker, F Delahaye, P Montagna, J Ossette, G Durand de Gevigney and PH Mikaeloff
Department of Cardiovascular Surgery, Hopital Cardiologique, Lyon, France.

From January 1979 to December 1990, 397 consecutive patients (mean age, 55 +/- 11 years) underwent mitral valve replacement with the St. Jude Medical valve. Associated procedures performed were 174 multiple valve replacements, 24 coronary artery bypass graftings, 25 tricuspid repairs, and 13 left ventricular myectomies. The continuous intravenous administration of heparin was started on the first postoperative day and maintained until effective oral anticoagulation, started on the seventh day, was achieved (INR, 3 to 4.5). Follow-up consisted of 2,402 patient-years (pt-y) (mean, 6.1 +/- 0.2 years) and was 97% complete. The early (30-day) mortality was 3.5%; the 5-year and 10-year actuarial survivals were 86% +/- 4% and 73% +/- 6%, respectively. Survival was less in patients who had been in an advanced preoperative functional class (p = 0.02) and in those who underwent multiple valve replacements (p = 0.05). The 5-year and 10-year survivals in patients who underwent isolated mitral valve replacement and who were in preoperative New York Heart Association functional class II and III, were 90% +/- 5% and 82% +/- 7%, respectively. The early and late mortality and the incidence of deaths resulting from heart failure and sudden deaths were higher in patients who had undergone multiple valve replacements (p = 0.05). In terms of all deaths, 47% (36/77) were valve related (including 12 sudden deaths, 0.50%/pt-y). Thromboembolic complications occurred in 44 patients, and these were broken down as follows: embolism, 1.46%/pt-y, and valve thrombosis, 0.37%/pt-y.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
T. Gudbjartsson, T. Absi, and S. Aranki
Mitral Valve Replacement
Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068.
[Full Text]


Home page
Card Surg AdultHome page
H. V. Schaff and R. M. Suri
Multiple Valve Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1129 - 1158.
[Full Text]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
T. Gudbjartsson, S. Aranki, and L. H. Cohn
Mechanical/Bioprosthetic Mitral Valve Replacement
Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986.
[Full Text]


Home page
Card Surg AdultHome page
H. V. Schaff and D. H. Marsh
Multiple Valve Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 1017 - 1045.
[Full Text]


Home page
Eur Heart J SupplHome page
R. Bergemann and E. Muller
Economic outcomes after heart valve replacement surgery in Germany
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q70 - Q72.
[Abstract] [PDF]


Home page
Eur Heart JHome page
N.M. Al-Saady and M. Sopher
Prothrombotic markers in atrial fibrillation: what is new?
Eur. Heart J., September 2, 2001; 22(18): 1635 - 1639.
[PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
P. Zhu and S. S. Feng
Fifteen-Year Experience With Shanghai Disc Valve Prosthesis
Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 182 - 186.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N M Al-Saady, O A Obel, and A J Camm
Left atrial appendage: structure, function, and role in thromboembolism
Heart, November 1, 1999; 82(5): 547 - 554.
[Abstract] [Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
W.R. E. Jamieson, R. T. Miyagishima, G. L. Grunkemeier, E. Germann, C. Henderson, G. J. Fradet, L. H. Burr, and S. V. Lichtenstein
Bileaflet mechanical prostheses performance in mitral position
Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Craver
CarboMedics(R) Prosthetic Heart Valve
Eur. J. Cardiothorac. Surg., January 1, 1999; 15(suppl_1): 3 - 11.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. K. Rosengart, M. O'Hara, S. J. Lang, W. Ko, N. Altorki, K. H. Krieger, and O. W. Isom
Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution
Ann. Thorac. Surg., November 1, 1998; 66(5): 1684 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
W.R. E. Jamieson, A. I. Munro, R. T. Miyagishima, G. L. Grunkemeier, L. H. Burr, S. V. Lichtenstein, and G. F. O. Tyers
Multiple mechanical valve replacement surgery comparison of St. Jude Medical and CarboMedics prostheses
Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. Grossi, A. C. Galloway, J. S. Miller, G. H. Ribakove, A. T. Culliford, R. Esposito, J. Delianides, P. M. Buttenheim, F. G. Baumann, F. C. Spencer, et al.
Valve Repair Versus Replacement For Mitral Insufficiency: When Is A Mechanical Valve Still Indicated?
J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 389 - 396.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
T. E. David, V. L. Gott, L. A. Harker, G. E. Miller Jr, D. C. Naftel, A. G. G. Turpie, and C. W. Akins
Mechanical Valves
Ann. Thorac. Surg., November 1, 1996; 62(5): 1567 - 1570.
[Full Text]


Home page
NEJMHome page
W. Vongpatanasin, L. D. Hillis, and R. A. Lange
Prosthetic Heart Valves
N. Engl. J. Med., August 8, 1996; 335(6): 407 - 416.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. L. Blackshear and J. A. Odell
Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation
Ann. Thorac. Surg., February 1, 1996; 61(2): 755 - 759.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
C. W. Akins
Results With Mechanical Cardiac Valvular Prostheses
Ann. Thorac. Surg., December 1, 1995; 60(6): 1836 - 1844.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.